fulvestrant has been researched along with estrone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Potter, BV; Purohit, A; Reed, MJ; Roberts, CJ; Williams, GJ | 1 |
| Newton, CJ | 1 |
| Biberger, C; von Angerer, E | 1 |
| Bélanger, A; Candas, B; Gauthier, S; Labrie, C; Labrie, F; Li, X; Martel, C; Mérand, Y; Provencher, L | 1 |
| Gorodeski, GI | 1 |
| Robinson, JA; Spelsberg, TC; Turner, RT; Waters, KM | 1 |
| Dubey, RK; Gillespie, DG; Imthurn, B; Jackson, EK; Keller, PJ; Zacharia, LC | 1 |
| Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
| Ansell, PJ; Ganjam, VK; Harada, N; Honda, S; Lubahn, DB; Newton, LG; Philips, BJ; Rottinghaus, GE; Welshons, WV | 1 |
| De Felici, M; Farini, D; La Sala, G | 1 |
| Coombes, RC; Januszewski, A; Palmieri, C; Stanway, S | 1 |
| Dias, NJ; Selcer, KW | 1 |
| Bazgier, V; Berka, K; Holcakova, J; Hrstka, R; Kolarova, T; Kudova, E; Kvasnica, M; Oklestkova, J; Rarova, L; Strnad, M; Tichy, V; Vonka, P | 1 |
2 review(s) available for fulvestrant and estrone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase II as Topic; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Steryl-Sulfatase; Sulfonic Acids; Tamoxifen | 2011 |
13 other study(ies) available for fulvestrant and estrone
| Article | Year |
|---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
Topics: Animals; Arylsulfatases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrone; Female; Fulvestrant; Liver; Mammary Neoplasms, Experimental; Rats; Rats, Wistar; Steryl-Sulfatase; Sulfatases; Tamoxifen; Time Factors | 1995 |
Estrogen receptor blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumour cells.
Topics: Animals; Cell Death; Culture Media; Culture Media, Conditioned; DNA Damage; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogen Antagonists; Estrone; Fulvestrant; Hydroxytestosterones; Luciferases; Pituitary Neoplasms; Prolactin; Rats; Receptors, Estrogen; Steroids; Time Factors; Tumor Cells, Cultured | 1995 |
2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cattle; Cell Division; Estradiol; Estrogen Antagonists; Estrone; Female; Fulvestrant; HeLa Cells; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Organ Size; Receptors, Estrogen; Sulfur; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured; Uterus; Vitellogenins | 1996 |
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Topics: Animals; Benzopyrans; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Fulvestrant; Mice; Mice, Inbred BALB C; Organ Size; Ovariectomy; Propionates; Receptors, Estrogen; Toremifene; Uterus; Vagina | 1998 |
Estrogen increases the permeability of the cultured human cervical epithelium by modulating cell deformability.
Topics: Actins; Cell Line; Cell Membrane Permeability; Cells, Cultured; Cervix Uteri; Chlorides; Diethylstilbestrol; Egtazic Acid; Epithelial Cells; Estradiol; Estriol; Estrogen Antagonists; Estrogens; Estrone; Female; Fulvestrant; Humans; Kinetics; Progesterone; Sodium; Tamoxifen | 1998 |
Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.
Topics: Alkaline Phosphatase; Bone Matrix; Cell Differentiation; Cell Line; Enzyme Induction; Estradiol; Estrogen Receptor alpha; Estrogens; Fulvestrant; Humans; Hydroxyestrones; Osteoblasts; Osteocalcin; Receptors, Estrogen; Recombinant Fusion Proteins; RNA, Messenger | 2000 |
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity.
Topics: Aorta; Becaplermin; Cell Division; Cells, Cultured; DNA; Enzyme Inhibitors; Estradiol; Estriol; Estrogen Antagonists; Estrogens; Estrone; Female; Fulvestrant; Humans; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis | 2000 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues.
Topics: Animals; Aromatase; Binding, Competitive; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens, Catechol; Female; Fulvestrant; Hydroxyestrones; Kidney; Liver; Male; Mice; Mice, Knockout; Ovary; Proteins; Receptors, Estrogen; Substrate Specificity; Tissue Distribution; Uterus | 2004 |
Estrogenic in vitro assay on mouse embryonic Leydig cells.
Topics: Animals; Biological Assay; Cell Differentiation; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrone; Female; Fulvestrant; Genes, Reporter; Humans; Leydig Cells; Luciferases; Male; Mice; Phytoestrogens; Response Elements; Testis; Transcription Factor AP-1; Transfection | 2010 |
Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
Topics: Cell Line; Cell Proliferation; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrone; Fulvestrant; Gene Expression Regulation, Enzymologic; Humans; Osteoblasts; RNA, Messenger; Steryl-Sulfatase | 2014 |
Small change - big consequence: The impact of C15-C16 double bond in a D‑ring of estrone on estrogen receptor activity.
Topics: Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrone; Female; Fulvestrant; Humans; Molecular Docking Simulation; Receptors, Estrogen; Tamoxifen | 2023 |